Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis

被引：0
作者：
Osamu Imataki
Yoshitsugu Kubota
Hiroaki Ohnishi
Akira Kitanaka
Toshihiko Ishida
Terukazu Tanaka
机构：
[1] Kagawa University,Division of Hematology, Department of Internal Medicine, Faculty of Medicine
[2] Kagawa University,Department of Transfusion Medicine, Faculty of Medicine
[3] Kagawa University,Department of Laboratory Medicine, Faculty of Medicine
[4] Kagawa University,Department of Internal Medicine, Faculty of Medicine
[5] Kagawa University,Environmental Health Sciences, Faculty of Medicine
来源：
Supportive Care in Cancer | 2011年 / 19卷
关键词：
Antifungal prophylaxis; Medical cost; Hematological malignancy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1657 / 1665
页数：8
相关论文
共 50 条
[41]   Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis [J].
Doering, Michaela ;
Hartmann, Ulrike ;
Erbacher, Annika ;
Lang, Peter ;
Handgretinger, Rupert ;
Mueller, Ingo .
BMC INFECTIOUS DISEASES, 2012, 12
[42]   Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis [J].
Michaela Döring ;
Ulrike Hartmann ;
Annika Erbacher ;
Peter Lang ;
Rupert Handgretinger ;
Ingo Müller .
BMC Infectious Diseases, 12
[43]   Effectiveness of Convalescent Plasma Therapy in COVID-19 Patients with Hematological Malignancies: A Systematic Review [J].
Shibeeb, Sapha ;
Ajaj, Ilham ;
Al-Jighefee, Hadeel ;
Abdallah, Atiyeh M. .
HEMATOLOGY REPORTS, 2022, 14 (04) :377-388
[44]   The role of meta-analysis in the evaluation of antifungal prophylaxis: authors' response [J].
Glasmacher, A ;
Prentice, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) :152-154
[45]   A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies [J].
Noori, Maryam ;
Azizi, Shadi ;
Varaki, Farhan Abbasi ;
Nejadghaderi, Seyed Aria ;
Bashash, Davood .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
[46]   Status and cost analysis of antimicrobial treatment of terminally ill patients with hematological malignancy in an acute hospital [J].
Chiba, Miyuki ;
Negishi, Miyako ;
Miyagawa, Sanae ;
Suzuki, Satoru ;
Sasai, Emiko ;
Sugai, Kazunori ;
Hagiwara, Shotaro .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (12) :1288-1293
[47]   Pulmonary infections in patients with and without hematological malignancies: diagnostic yield and safety of flexible bronchoscopy-a retrospective analysis [J].
Panse, Jens ;
von Schwanewede, Kai ;
Jost, Edgar ;
Dreher, Michael ;
Mueller, Tobias .
JOURNAL OF THORACIC DISEASE, 2020, 12 (09) :4860-4867
[48]   Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents [J].
Kim, Si-Hyun ;
Choi, Jae-Ki ;
Cho, Sung-Yeon ;
Lee, Hyo-Jin ;
Park, Sun Hee ;
Choi, Su-Mi ;
Lee, Dong-Gun ;
Choi, Jung-Hyun ;
Yoo, Jin-Hong ;
Lee, Jong-Wook .
MEDICAL MYCOLOGY, 2018, 56 (02) :197-206
[49]   COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study [J].
Tamayo-Velasco, Alvaro ;
Lopez-Herrero, Rocio ;
Gomez-Garcia, Lara Maria ;
Sanchez-de Prada, Laura ;
Aguilar-Monserrate, Gerardo ;
Martin-Fernandez, Marta ;
Bardaji-Carrillo, Miguel ;
Alvaro-Meca, Alejandro ;
Tamayo, Eduardo ;
Resino, Salvador ;
Miramontes-Gonzalez, Jose Pablo ;
Penarrubia-Ponce, Maria Jesus .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (06) :939-946
[50]   COVID-19 in hematological malignancy patients A protocol for a systematic review and meta-analysis [J].
Chen, Can ;
Weng, Qianping ;
Li, Yiwei ;
Shi, Pengfei ;
Qian, Shenxian .
MEDICINE, 2020, 99 (35)
12345